Vivo Capital Surplus Fund VIII, L.P., 10% Owner at Terns Pharmaceuticals, Inc. (TERN), bought 3,747,260 shares at $2.99 ($10.3M) on 2022-08-15, disclosed to the SEC on 2022-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.98 | 1,123,021 | $3.3M | 32.4% |
| 2 | $2.98 | 1,123,021 | $3.3M | 32.4% |
| 3 | $2.99 | 1,218 | $4K | 0.0% |
| 4 | $2.42 | 1,500,000 | $3.6M | 35.2% |
| Total | $2.76 avg | 3,747,260 | $10.3M | 100% |
| Filing → |
| IMPL | BUY | 2021-04-29 | $8.6M | — | Filing → |
| ALGS | BUY | 2020-10-20 | $8.3M | — | Filing → |
| CRNX | SELL | 2020-04-17 | $10.1M | — | Filing → |